Bundling of Wyeth Protonix Sales to Hospitals Tied to Medicaid Fraud, DoJ Says
A whistleblower suit against Wyeth appears to be the first case alleging that a firm's bundling contracts resulted in Medicaid fraud
You may also be interested in...
Pfizer Protonix Settlement May Deter Price Bundling
$784.6m fine will resolve claims that Wyeth subsidiary paid hospitals steep discounts if they purchased both oral and IV Protonix while reporting higher prices to the government.
Pfizer Litigation Strategy: Business Focus, Legal Alliance Drive Successes
Pfizer’s litigation department scored several key victories in the past year, which the company chalks up to its business approach to running cases and the teamwork of its law firms.
Pfizer Settles Protonix Off-Label Allegations – Pricing Investigation Still Unresolved
Pfizer finalizes a $55 million settlement with the Department of Justice concerning Wyeth’s Protonix promotional practices; a separate probe of alleged bundling of Protonix sales to hospitals continues.